THERAPEUTICAL USAGE OF FLUOROQUINOLONES IN POULTRY PRODUCTION INFLUENCE ON MEAT SAFETY – RESIDUES IN EDIBLE TISSUES
Jelena Petrović, Marcela Šepernada, S. Stefanović and 3 more
Archives of Veterinary Medicine · 2012
doi:10.46784/e-avm.v4i2.181 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Current most important side effects of antimicrobial drugs usage are veterinary drug residues in edible animal tissues and development of resistance in food borne pathogens. Enrofloxacine and flumequine are fluoroquinolone antimicrobials licensed in Serbia for use in poultry treatment. Elimination of health risk for consumers is usually made by examination of the target tissue residues of flumequine and enrofloxacine (with its main metabolite ciprofloxacine). After correct application of enrofloxacine and flumequine tissue residue levels descrease to permitted quantities (below MRL) (Maximum Residue Limit) in prescribed withdrawal period. But even after expiration of withdrawal period residues of enrofloxacine are still present in edible animal tissues. Residues of enrofloxacine below MRL can be detected in meat nine days after the end of treatment, however, residues in liver are present much longer. The residues were detected in liver until 22nd post treatment day.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.